News (70)

Transcript : Eli Lilly and Company, Q1 2024 Earnings Call, Apr 30, 2024
Eli Lilly and : Q1 Earnings 2024 Earnings Presentation PU
Transcript : Eli Lilly and Company Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-06-2024 09:10 AM
Lilly to Participate in Cowen's 44th Annual Health Care Conference PR
Eli Lilly and Company - Philip Johnson to Retire as Lilly Treasurer AQ
Philip Johnson to Retire as Lilly Treasurer PR
Transcript : Eli Lilly and Company, Q4 2023 Earnings Call, Feb 06, 2024
Novo Nordisk, Lilly see insatiable demand for weight-loss drugs RE
Transcript : Eli Lilly and Company, Q3 2023 Earnings Call, Nov 02, 2023
Transcript : Eli Lilly and Company, Q2 2023 Earnings Call, Aug 08, 2023
Transcript : Eli Lilly and Company Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 01:20 PM
Lilly to Participate in Goldman Sachs Global Healthcare Conference PR
Lilly's Social Impact Venture Capital Portfolio Poised to Grow to $300 Million with New $50 Million Allocation PR
Transcript : Eli Lilly and Company, Q1 2023 Earnings Call, Apr 27, 2023
Transcript : Eli Lilly and Company, Q4 2022 Earnings Call, Feb 02, 2023
Eli Lilly and : Q4 2022 Lilly Press Release PU
Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook PR
Transcript : Eli Lilly and Company Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03:45 PM
U.S. FDA flags shortage of Eli Lilly's new diabetes drug Mounjaro RE
Transcript : Eli Lilly and Company, 2023 Guidance/Update Call, Dec 13, 2022
Eli Lilly Expects 2023 Sales Growth, Plans Launch of Four New Medicines DJ
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines PR
Transcript : Eli Lilly and Company, Q3 2022 Earnings Call, Nov 01, 2022
Transcript : Eli Lilly and Company Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11:10 AM
Lilly to Participate in Morgan Stanley 20th Annual Global Healthcare Conference PR
Transcript : Eli Lilly and Company, Q2 2022 Earnings Call, Aug 04, 2022
Eli Lilly and : Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines and Pipeline Advancements - Form 8-K PU
Eli Lilly and : Q2 2022 Lilly Press Release PU
Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines and Pipeline Advancements PR
Transcript : Eli Lilly and Company, Q1 2022 Earnings Call, Apr 28, 2022
Transcript : Eli Lilly and Company Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022 10:30 AM
Lilly to Participate in Cowen Health Care Conference PR
Transcript : Eli Lilly and Company, Q4 2021 Earnings Call, Feb 03, 2022
Eli Lilly and : Lilly Reports Solid Fourth-Quarter and Full-Year 2021 Financial Results, Recent Late-Stage Pipeline Successes Set Up Next Wave of Innovative Medicines for Patients - Form 8-K PU
Eli Lilly and : Q4 2021 Lilly Press Release PU
Lilly Reports Solid Fourth-Quarter and Full-Year 2021 Financial Results, Recent Late-Stage Pipeline Successes Set Up Next Wave of Innovative Medicines for Patients PR
Lilly sees 2022 profit above estimates on boost from potential new drugs RE
Transcript : Eli Lilly and Company, 2022 Guidance/Update Call, Dec 15, 2021
Eli Lilly Seeks Bolt-On Acquisitions CI
Eli Lilly and : Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting - Form 8-K PU
Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting PR
Transcript : Eli Lilly and Company, Q3 2021 Earnings Call, Oct 26, 2021
Eli Lilly and : Lilly Prices First Sustainability Bond to Advance Global ESG Strategy PR
Eli Lilly Prices First Sustainability Bond DJ
Transcript : Eli Lilly and Company Presents at Citi’s 16th Annual BioPharma Virtual Conference, Sep-09-2021 09:45 AM
12NextSee all

Insiders

Picture Anat Ashkenazi
Anat Ashkenazi

Anat Ashkenazi is on the board of Varian Medical Systems, Inc. and Maravai Lifesciences Holdings, Inc. and Chief Financial Officer & Senior Vice President at Eli Lilly & Co. Ms. Ashkenazi previously was Chief Financial Officer, Controller & Senior VP at Lilly Research Laboratories. Anat Ashkenazi received an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Tel-Aviv University.





Picture Amit Ashkenazi
Amit Ashkenazi

Amit Ashkenazi is Chief Strategy Officer at Artlist, where he is leading the company’s strategy and managing it’s organic and inorganic growth engines.
Amit’s areas of responsibilities also include Corporate Development, Enterprise Sales and partnerships.
Amit is also serving as an advisory board member at Guesty.
Before joining Artlist, Amit served as VP of Business Strategy at Fiverr (NYSE:FVRR) where he led Fiverr’s strategy and managed its strategic initiatives, corporate development and M&As.
Formerly, he was a Partner at Viola Growth, a technology growth capital fund that focuses on investing in Israeli-related global technology companies at their expansion phase.
His investment areas included eCommerce, SaaS, Digital Media, and FinTech.
Prior to joining Viola, Amit worked as a senior consultant at Ernst & Young providing Transaction Advisory Services such as due diligence (buy-side and sell-side), business modeling, and management consulting for both public and private companies in numerous industries.
He also provided Assurance services focusing on high-tech companies.
Amit is a Certified Public Accountant in Israel and holds a BA, Magna Cum Laude, in Business Administration & Accounting from the College of Management and an MBA, Magna Cum Laude, from Tel Aviv University.





Picture Ely E. Ashkenazi
Ely E. Ashkenazi

Ely E.
Ashkenazi
currently works at SDI Technologies, Inc., as Chairman.


Picture Ezra S. Ashkenazi
Ezra S. Ashkenazi

Ezra S.
Ashkenazi
is currently the President & Chief Executive Officer of iHome Audio and the President of SDI Technologies, Inc.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW